Octave® Bioscience, Inc. Announces Real-World Study Using its Multimodal Precision Care Solution for Multiple Sclerosis Patient Management

MENLO PARK, Calif.–(BUSINESS WIRE)–Octave® Bioscience, Inc., announced that it plans to conduct an observational, real-world study with Biogen (Nasdaq: BIIB) as the sponsor.
Click here to view original post